AccessibilityHelpAbout Us
Alcidion Group logo

Alcidion Group(ASX) ALC

Market CapA$141.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)+65%
5 Year-73%
1 Year+19%
1 Month+17%
A$0.11
+0.00%
+0.00Today
Alcidion Group last closing stock price
MetricPriceDate
Last closeAUD 0.112026-09-11
Alcidion Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%AUD 0.112026-09-04
1 month+16.67%AUD 0.092026-08-12
3 month+5%AUD 0.102026-06-12
Year to date+0%AUD 0.112025-12-31
1 year+19.32%AUD 0.092025-09-11
3 year-8.7%AUD 0.122023-09-12
5 year-73.08%AUD 0.392021-09-10
Since inception+64.67%AUD 0.062015-08-19

Alcidion Group Financials at a Glance

Market Cap

A$141.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$92.43M

Net Income (TTM)

A$3.94M

EPS (TTM)

A$0.00

P/E Ratio

61.76

Dividend

A$0.00

Beta (Volatility)

-0.04 (Low)

Price

A$0.11

Volume

550,083

Open

A$0.10

Previous Close

A$0.11

Daily Range

A$0.10 - A$0.11

52-Week Range

A$0.08 - A$0.15

Estimated Earnings Date

Feb 25, 2027

ALC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alcidion Group

Alcidion Group Limited operates as a healthcare technology firm, specializing in the creation and licensing of software products across Australia, New Zealand, and the United Kingdom. The company focuses on enabling intelligent healthcare delivery through its innovative solutions.

Products and Services
  • Miya Precision: A platform built on the FHIR standard for healthcare delivery
  • Smartpage: A mobile and web-based system for hospital communications
  • Patientrack: A tool for real-time patient monitoring and risk screening
Growth Outlook
  • Recent quarterly revenue reached AUD 26.17 million, indicating strong demand
  • Trailing twelve months (TTM) revenue shows a consistent upward trend
  • Expansion into the UK market presents significant growth opportunities
Financial Highlights
  • Net income for the latest quarter was AUD 955,000, reflecting operational efficiency
  • Cash and cash equivalents increased to AUD 20.64 million, enhancing liquidity
  • Operating cash flow for the latest quarter was AUD 9.41 million, indicating strong cash generation
Alcidion Group Limited is positioned in the healthcare information services industry, providing essential software solutions that enhance clinical and administrative workflows. The company's flagship product, Miya Precision, leverages advanced technology to improve patient care and operational efficiency. With a focus on innovation and market expansion, Alcidion is well-placed to capitalize on the growing demand for healthcare technology solutions. Recent financial performance highlights a positive trajectory, with increasing revenues and strong cash flow, suggesting a robust operational foundation. The company's strategic initiatives in expanding its market presence, particularly in the UK, further enhance its growth potential, making it an intriguing option for investors interested in the healthcare technology sector.
AI Generated • Aug 26, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

141

CEO

Kate Quirke

Website

www.alcidion.com.au

Headquarters

South Yarra, VIC 3141, AU

ALC Financials

Key Financial Metrics (TTM)

Gross Margin

17.75%

Operating Margin

4.94%

Net Income Margin

4.42%

Return on Equity

2.53%

Return on Capital

2.78%

Return on Assets

1.87%

Earnings Yield

1.62%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$141.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.35B

Volume

550.08K

Avg. Volume

1.10M

Financials (TTM)

Gross Profit

A$45.15M

Operating Income

A$10.36M

EBITDA

A$6.86M

Operating Cash Flow

A$12.61M

Capital Expenditure

-A$351.00K

Free Cash Flow

A$12.26M

Cash & ST Invst.

A$20.64M

Total Debt

A$814.00K

Alcidion Group Performance Analysis

Alcidion Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 40,400,00017.6%
20242024-06-30AUD 37,057,000-8.3%
20252025-06-30AUD 40,786,00010.1%
20262026-06-30AUD 51,641,00026.6%
Alcidion Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-2.0%
Q42025-06-3031.2%
Q22025-12-3110.0%
Q42026-06-302.8%
Alcidion Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.00-26.3%
20242024-06-30AUD -0.01128.6%
20252025-06-30AUD 0.00N/A
20262026-06-30AUD 0.0041.7%
Alcidion Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3176.7%
Q42025-06-30371.4%
Q22025-12-31-47.4%
Q42026-06-30-30.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$26.17M

+45.4%

Gross Profit

A$4.05M

-73.3%

Gross Margin

15.49%

N/A

Market Cap

A$141.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$1.01M

N/A

Employees

141

N/A

Net Income

A$955.00K

+123.4%

EBITDA

A$351.00K

+121.9%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$20.64M

+75.0%

Total Debt

A$814.00K

-52.0%

Accounts Receivable

A$6.06M

+16.2%

Inventory

A$0.00

N/A

Long Term Debt

A$280.00K

-71.9%

Short Term Debt

A$534.00K

-23.4%

Return on Assets

1.87%

N/A

Return on Invested Capital

2.62%

N/A

Free Cash Flow

A$9.22M

+115.1%

Operating Cash Flow

A$9.41M

+119.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ONE.AXOneview Healthcare PLC
A$0.17+0.00%
VLS.AXVita Life Sciences Limited
A$2.76+0.00%
RCE.AXRecce Pharmaceuticals Ltd
A$0.36-4.05%
ALA.AXArovella Therapeutics Limited
A$0.06-1.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
KHCKraft Heinz
$24.60+0.01%
ACVAACV Auctions
$10.41+0.44%
TNONTenon Medical
$5.93+0.12%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$19.16+0.03%

Questions About ALC

What is the current price of Alcidion Group?

Alcidion Group is trading at A$0.11 per share.

What is the 52-week range for Alcidion Group?

Over the past 52 weeks, Alcidion Group has traded between A$0.08 and A$0.15.

How much debt does Alcidion Group have?

As of the most recent reporting period, Alcidion Group reported total debt of A$814.00K.

How much cash does Alcidion Group have on hand?

Alcidion Group reported A$20.64M in cash and cash equivalents in its most recent financial results.

What is Alcidion Group’s dividend yield?

Alcidion Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services